Staska Pharmaceuticals, Inc.

FDA Regulatory Profile

Staska Pharmaceuticals, Inc. appears in FDA public data with 1 recall — including 1 Class I (most serious) —, 0 510(k) clearances, 1 FDA inspection, and 1 compliance action on record. Its most recent recall (D-0040-2025, Class I) was initiated on September 30, 2024.

Summary

Total Recalls
1 (1 Class I)
510(k) Clearances
0
Inspections
1
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0040-2025Class IAscorbic Acid Inj. Solution, 25,000mg/50mL (500mg/mL), 50mL single use vial, Rx only, Staska PharmacSeptember 30, 2024